BioPharma
29 March, 2023 | Wednesday | News
Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Associated Antigen (TAA) Claudin 18.2. The Phase I CLINCH trial&n...
Lab
31 March, 2023 | Friday | News
The system's Liquid Manager feature offers predefined pipette settings and technique hints for a variety of liquids, ensuring consistent and accurate results in several applications. Users can also define their...
BioTech
31 March, 2023 | Friday | Company results
Revenue of the Group for the year ended December 31, 2022 was approximately US$625.7 million, representing an increase of 27.7% as compared with approximately US$490.1 million for the...
Contract Services
01 April, 2023 | Saturday | News
Very promising preclinical results of the apoA-I biovector in an acute inflammation model Development of safe corticoids to limit traditional corticoid-related side effects when used in AMD or DME Project t...
Consumer Health
29 March, 2023 | Wednesday | News
The program will enable Verbal Beginnings' clients, families, and caregivers to remotely report on the health outcomes that matter most to them, including social communication, behavioral functioning, and quali...
White Paper
02 March, 2023 | Thursday | News
Product Spot Light
31 March, 2023 | Friday | News
Premium Article
31 March, 2023 | Friday | News
Bio Invest
31 March, 2023 | Friday | Company results
Biopharma APAC Infomercial